苯达莫司汀-利妥昔单抗化疗继发穿通性毛囊炎：一例报告 - Suppr

Suppr

超能文献

Perforating Folliculitis Secondary to Bendamustine-Rituximab Chemotherapy: A Case Report.

作者信息

Monteiro Rowan, Bhat Ishwara, Abraham Anil, Rajlakshmi T

机构信息

Department of Dermatology and Pathology, St. Johns Medical College, Bengaluru, Karnataka, India.

出版信息

Indian Dermatol Online J. 2017 Jul-Aug;8(4):290-292. doi: 10.4103/2229-5178.209602.

DOI:10.4103/2229-5178.209602

PMID:28761855

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5518590/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5af8/5518590/69aa41989b6e/IDOJ-8-290-g001.jpg

相似文献

Perforating Folliculitis Secondary to Bendamustine-Rituximab Chemotherapy: A Case Report.

Indian Dermatol Online J. 2017 Jul-Aug;8(4):290-292. doi: 10.4103/2229-5178.209602.

[Perforating folliculitis].

Ann Dermatol Venereol. 1990;117(8):515-20.

Perforating folliculitis in a patient with cystic fibrosis.

Pediatr Dermatol. 2010 Nov-Dec;27(6):660-1. doi: 10.1111/j.1525-1470.2010.01329.x.

Rituximab plus bendamustine or chlorambucil for chronic lymphocytic leukemia: primary analysis of the randomized, open-label MABLE study.

Haematologica. 2018 Apr;103(4):698-706. doi: 10.3324/haematol.2017.170480. Epub 2018 Feb 1.

Venetoclax-Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia.

N Engl J Med. 2018 Mar 22;378(12):1107-1120. doi: 10.1056/NEJMoa1713976.

Comparative Effectiveness of Chemotherapy, Rituximab, and Bendamustine in Medicare Beneficiaries With Mantle-Cell Lymphoma.

Clin Lymphoma Myeloma Leuk. 2019 Nov;19(11):e616-e623. doi: 10.1016/j.clml.2019.08.014. Epub 2019 Aug 30.

Bendamustine-120 plus rituximab therapy for relapsed or refractory follicular lymphoma: a multicenter phase II study.

Ann Hematol. 2019 Sep;98(9):2131-2138. doi: 10.1007/s00277-019-03750-7. Epub 2019 Jul 8.

Bendamustine plus rituximab versus fludarabine plus rituximab for patients with relapsed indolent and mantle-cell lymphomas: a multicentre, randomised, open-label, non-inferiority phase 3 trial.

Lancet Oncol. 2016 Jan;17(1):57-66. doi: 10.1016/S1470-2045(15)00447-7. Epub 2015 Dec 5.

Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial.

Lancet. 2013 Apr 6;381(9873):1203-10. doi: 10.1016/S0140-6736(12)61763-2. Epub 2013 Feb 20.

Bendamustine in chronic lymphocytic leukemia and refractory lymphoma.

Semin Hematol. 2008 Jul;45(3 Suppl 2):S7-10. doi: 10.1053/j.seminhematol.2008.07.006.

引用本文的文献

Nilotinib-induced Perforating Folliculitis: Two Cases.

Int J Trichology. 2018 Mar-Apr;10(2):89-91. doi: 10.4103/ijt.ijt_85_17.

本文引用的文献

Perforating folliculitis in a patient treated with nilotinib: a further evidence of C-kit involvement.

Am J Dermatopathol. 2014 Jul;36(7):592-3. doi: 10.1097/DAD.0b013e31828cf3b7.

Severe cutaneous interface drug eruption associated with bendamustine.

Dermatol Online J. 2010 Jul 15;16(7):1.

Perforating folliculitis, angioedema, hand-foot syndrome--multiple cutaneous side effects in a patient treated with sorafenib.

J Dtsch Dermatol Ges. 2009 May;7(5):449-52. doi: 10.1111/j.1610-0387.2009.07017.x. Epub 2009 Jan 29.

Perforating folliculitis associated with tumour necrosis factor-alpha inhibitors administered for rheumatoid arthritis.

Br J Dermatol. 2007 Feb;156(2):368-71. doi: 10.1111/j.1365-2133.2006.07598.x.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验